Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002180526 | SCV002344572 | likely benign | Landau-Kleffner syndrome | 2024-11-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002352797 | SCV002647759 | uncertain significance | Inborn genetic diseases | 2018-12-19 | criteria provided, single submitter | clinical testing | The p.F195L variant (also known as c.583T>C), located in coding exon 2 of the GRIN2A gene, results from a T to C substitution at nucleotide position 583. The phenylalanine at codon 195 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |